<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00763360</url>
  </required_header>
  <id_info>
    <org_study_id>AUS-S-07-01</org_study_id>
    <nct_id>NCT00763360</nct_id>
  </id_info>
  <brief_title>To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.</brief_title>
  <official_title>To Compare the Ability of DiscoVisc® Ophthalmic Viscosurgical Device (OVD) to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to assess how DisCoVisc Ophthalmic Viscosurgical Device (OVD)
      compares with Healon and Amvisc Plus in the protection of corneal endothelial cells, and the
      ability to maintain anterior chamber space, in routine cataract surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial Cell Count Change From Baseline</measure>
    <time_frame>one month</time_frame>
    <description>Change in endothelial cell count compared to baseline. Endothelial cell count peformed by counting of cells on photographic image of endothelium.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Investigator Reported Space Maintenance</measure>
    <time_frame>During surgical procedure</time_frame>
    <description>Maintenance of the anterior chamber/dome during cataract surgery. This was rated by the surgeon in one of 4 categories: &quot;Full Chamber Maintained&quot;, &quot;Working Space Maintained&quot;, &quot;Shallow&quot;, &quot;Flat&quot;. Space maintenance was reported during Capsulorhexis, Hydrodissection, Phacoemulsification, and IOL insertion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Corneal Thickness</measure>
    <time_frame>1 month</time_frame>
    <description>Change in corneal thickness from baseline, measured in millimeters. Measurement performed by pachymetry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Clarity</measure>
    <time_frame>2 weeks</time_frame>
    <description>Evaluation of corneal clarity as assessed by levels of aqueous flare and aqueous cells. Evaluations were based on the surgeons judgement and graded on a scale. Aqueous flare was graded on the following scale: No visible flare, mild, moderate, severe. Aqueous cells were graded on the following scale: no cells, 1-20 cells, 10-50 cells, too many cells to count, cells frozen.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">184</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>DisCoVisc®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DisCoVisc® Ophthalmic Viscosurgical Device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amvisc Plus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Amvisc Plus</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DisCoVisc®</intervention_name>
    <description>Injection of DisCoVisc® Ophthalmic Viscosurgical Device (OVD) into the anterior chamber prior to and throughout the cataract surgery procedure</description>
    <arm_group_label>DisCoVisc®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Healon</intervention_name>
    <description>Injection of Healon into the anterior chamber prior to and throughout the cataract surgery procedure</description>
    <arm_group_label>Healon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amvisc Plus</intervention_name>
    <description>Injection of Amvisc Plus into the anterior chamber prior to and throughout the cataract surgery procedure</description>
    <arm_group_label>Amvisc Plus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients able to understand and sign a document of informed consent;

          -  Patients aged ≥49 years with age-related cataract formation;

          -  Patients planning to undergo surgical removal of cataract by phacoemulsification with
             implantation of a posterior chamber intraocular lens;

          -  Patients that have healthy eyes excluding the formation of cataract.

        Exclusion Criteria:

          -  pseudoexfoliation syndrome with glaucoma or zonular compromise in the operative eye;

          -  A congenital ocular anomaly (e.g., aniridia, congenital cataract) in the operative
             eye;

          -  Iris atrophy in the operative eye;

          -  Glaucoma (including pseudoexfoliation or pigmentary) or any causes of compromised
             outflow in the operative eye;

          -  Any abnormality which prevents reliable Goldmann applanation tonometry in the
             operative eye;

          -  Ocular hypertension (lntraocular Pressure (IOP) &gt; 21 mmHg) in the operative eye at the
             baseline exam;

          -  Corneal abnormality that results in a poor endothelial cell photograph and prevents
             reliable endothelial cell density measurement;

          -  Baseline endothelial cell density &lt; 1500 cells/mm2, in the operative eye;

          -  Planned multiple procedures during cataract/Intraocular Lens (IOL) implantation
             surgery (e.g., trabeculoplasty, corneal transplant). NOTE: A minor relaxing keratotomy

          -  Patients 48 years of age or younger;

          -  Proliferative diabetic retinopathy in the operative eye;

          -  Uncontrolled diabetes mellitus;

          -  Marfan's Syndrome;

          -  An ocular disease and/or condition that may compromise results;

          -  A history of chronic or recurrent inflammatory eye disease (e.g. iritis, scleritis,
             uveitis, iridocyclitis, rubeosis iritis) in the operative eye;

          -  Lens for the correction of astigmatism may be performed;

          -  Previous ocular trauma to the operative eye (this includes previous intraocular
             surgery and traumatic cataract). NOTE: history of non-invasive laser surgery (with the
             exception of laser treatment for PDR) is acceptable for inclusion;

          -  A non-functional fellow eye;

          -  Participation in any other clinical study within the 30 days before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>49 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alcon Call Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2008</study_first_submitted>
  <study_first_submitted_qc>September 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <results_first_submitted>December 20, 2011</results_first_submitted>
  <results_first_submitted_qc>December 20, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 24, 2012</results_first_posted>
  <last_update_submitted>December 20, 2011</last_update_submitted>
  <last_update_submitted_qc>December 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cataract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were undergoing a cataract operation and were recruited from surgery during 2008 to 2010</recruitment_details>
      <pre_assignment_details>Patients were screened prior to cataract operation</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>DisCoVisc®</title>
          <description>DisCoVisc® Ophthalmic Viscosurgical Device</description>
        </group>
        <group group_id="P2">
          <title>Healon</title>
          <description>Healon</description>
        </group>
        <group group_id="P3">
          <title>Amvisc Plus</title>
          <description>Amvisc Plus</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="60"/>
                <participants group_id="P3" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="58"/>
                <participants group_id="P3" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>DisCoVisc®</title>
          <description>DisCoVisc® Ophthalmic Viscosurgical Device</description>
        </group>
        <group group_id="B2">
          <title>Healon</title>
          <description>Healon</description>
        </group>
        <group group_id="B3">
          <title>Amvisc Plus</title>
          <description>Amvisc Plus</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="61"/>
            <count group_id="B2" value="60"/>
            <count group_id="B3" value="63"/>
            <count group_id="B4" value="184"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.97" spread="9.03"/>
                    <measurement group_id="B2" value="75.56" spread="7.6"/>
                    <measurement group_id="B3" value="75.51" spread="8.49"/>
                    <measurement group_id="B4" value="75.01" spread="8.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Endothelial Cell Count Change From Baseline</title>
        <description>Change in endothelial cell count compared to baseline. Endothelial cell count peformed by counting of cells on photographic image of endothelium.</description>
        <time_frame>one month</time_frame>
        <population>Only those participants that had endothelial cell counts at both baseline and follow-up were included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>DisCoVisc®</title>
            <description>DisCoVisc® Ophthalmic Viscosurgical Device</description>
          </group>
          <group group_id="O2">
            <title>Healon</title>
            <description>Healon</description>
          </group>
          <group group_id="O3">
            <title>Amvisc Plus</title>
            <description>Amvisc Plus</description>
          </group>
        </group_list>
        <measure>
          <title>Endothelial Cell Count Change From Baseline</title>
          <description>Change in endothelial cell count compared to baseline. Endothelial cell count peformed by counting of cells on photographic image of endothelium.</description>
          <population>Only those participants that had endothelial cell counts at both baseline and follow-up were included in this analysis.</population>
          <units>Percent change from baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="58"/>
                <count group_id="O3" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.91" spread="16.49"/>
                    <measurement group_id="O2" value="-5.11" spread="19.41"/>
                    <measurement group_id="O3" value="-4.92" spread="13.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Investigator Reported Space Maintenance</title>
        <description>Maintenance of the anterior chamber/dome during cataract surgery. This was rated by the surgeon in one of 4 categories: &quot;Full Chamber Maintained&quot;, &quot;Working Space Maintained&quot;, &quot;Shallow&quot;, &quot;Flat&quot;. Space maintenance was reported during Capsulorhexis, Hydrodissection, Phacoemulsification, and IOL insertion.</description>
        <time_frame>During surgical procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DisCoVisc®</title>
            <description>DisCoVisc® Ophthalmic Viscosurgical Device</description>
          </group>
          <group group_id="O2">
            <title>Healon</title>
            <description>Healon</description>
          </group>
          <group group_id="O3">
            <title>Amvisc Plus</title>
            <description>Amvisc Plus</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Reported Space Maintenance</title>
          <description>Maintenance of the anterior chamber/dome during cataract surgery. This was rated by the surgeon in one of 4 categories: &quot;Full Chamber Maintained&quot;, &quot;Working Space Maintained&quot;, &quot;Shallow&quot;, &quot;Flat&quot;. Space maintenance was reported during Capsulorhexis, Hydrodissection, Phacoemulsification, and IOL insertion.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
                <count group_id="O2" value="58"/>
                <count group_id="O3" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Capsulorhexis - full chamber maintained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Capsulorhexis - working space maintained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Capsulorhexis - shallow</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Capsulorhexis - flat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydrodissection - full chamber maintained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydrodissection - working space maintained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydrodissection - shallow</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydrodissection - flat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phacoemulsification - full chamber maintained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="55"/>
                    <measurement group_id="O3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phacoemulsification - working space maintained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phacoemulsification - shallow</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phacoemulsification - flat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IOL insertion - full chamber maintained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IOL insertion - working space maintained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IOL insertion - shallow</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IOL insertion - flat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Corneal Thickness</title>
        <description>Change in corneal thickness from baseline, measured in millimeters. Measurement performed by pachymetry.</description>
        <time_frame>1 month</time_frame>
        <population>Subjects that did not have both baseline and 1 month values were not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>DisCoVisc®</title>
            <description>DisCoVisc® Ophthalmic Viscosurgical Device</description>
          </group>
          <group group_id="O2">
            <title>Healon</title>
            <description>Healon</description>
          </group>
          <group group_id="O3">
            <title>Amvisc Plus</title>
            <description>Amvisc Plus</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Corneal Thickness</title>
          <description>Change in corneal thickness from baseline, measured in millimeters. Measurement performed by pachymetry.</description>
          <population>Subjects that did not have both baseline and 1 month values were not included in this analysis.</population>
          <units>millimeters</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="57"/>
                <count group_id="O3" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="0.04"/>
                    <measurement group_id="O2" value="0.54" spread="0.04"/>
                    <measurement group_id="O3" value="0.53" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Clarity</title>
        <description>Evaluation of corneal clarity as assessed by levels of aqueous flare and aqueous cells. Evaluations were based on the surgeons judgement and graded on a scale. Aqueous flare was graded on the following scale: No visible flare, mild, moderate, severe. Aqueous cells were graded on the following scale: no cells, 1-20 cells, 10-50 cells, too many cells to count, cells frozen.</description>
        <time_frame>2 weeks</time_frame>
        <population>Data from subjects for whom this evaluation was not performed is not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>DisCoVisc®</title>
            <description>DisCoVisc® Ophthalmic Viscosurgical Device</description>
          </group>
          <group group_id="O2">
            <title>Healon</title>
            <description>Healon</description>
          </group>
          <group group_id="O3">
            <title>Amvisc Plus</title>
            <description>Amvisc Plus</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Clarity</title>
          <description>Evaluation of corneal clarity as assessed by levels of aqueous flare and aqueous cells. Evaluations were based on the surgeons judgement and graded on a scale. Aqueous flare was graded on the following scale: No visible flare, mild, moderate, severe. Aqueous cells were graded on the following scale: no cells, 1-20 cells, 10-50 cells, too many cells to count, cells frozen.</description>
          <population>Data from subjects for whom this evaluation was not performed is not included in this analysis.</population>
          <units>units on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
                <count group_id="O2" value="58"/>
                <count group_id="O3" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Aqueous flare - no visible flare</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aqueous flare - mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="54"/>
                    <measurement group_id="O3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aqueous flare - moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aqueous flare - severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aqueous cells - no cells</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aqueous cells - 1-10 cells</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aqueous cells - 10-50 cells</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aqueous cells - too many cells to count</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aqueous cells - cells frozen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 month</time_frame>
      <desc>All adverse events were recorded by Principal Investigator.</desc>
      <group_list>
        <group group_id="E1">
          <title>DisCoVisc®</title>
          <description>DisCoVisc® Ophthalmic Viscosurgical Device</description>
        </group>
        <group group_id="E2">
          <title>Healon</title>
          <description>Healon</description>
        </group>
        <group group_id="E3">
          <title>Amvisc Plus</title>
          <description>Amvisc Plus</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>888.451.3937; 817.568.6725</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

